Federal award (DEFINITIVE CONTRACT, fiscal year 2023)
Recipient: DAXOR CORPORATION
Awarding agency: Department of Defense / Defense Health Agency
Funding agency: Department of Defense / Defense Health Agency
Period of performance: 2023-07-03 to 2025-11-02
Current total value of award: $1649996.73
Description: DHA SBIR PHASE II AND PHASE II ENHANCEMENT H2S-0039 (MONTHS 1-23) TITLED DIRECT BLOOD VOLUME ANALYZER FOR IMPROVEMENT OF COMBAT CASUALTY CARE.